SALIM VIRANI to United States
This is a "connection" page, showing publications SALIM VIRANI has written about United States.
Connection Strength
8.421
-
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2024 American Heart Association Scientific Sessions. Curr Atheroscler Rep. 2025 Feb 06; 27(1):30.
Score: 0.083
-
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2024 American College of Cardiology Conference. Curr Atheroscler Rep. 2024 Aug; 26(8):367-381.
Score: 0.079
-
Trends in cardiovascular mortality in the United States from 1968 to 2019: analysis of the CDC WONDER database. Eur J Prev Cardiol. 2024 Mar 27; 31(5):e33-e35.
Score: 0.078
-
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2023 American Heart Association Scientific Sessions. Curr Atheroscler Rep. 2024 04; 26(4):119-131.
Score: 0.078
-
Racial and ethnic disparities in cardiovascular disease - analysis across major US national databases. J Natl Med Assoc. 2024 Jun; 116(3):258-270.
Score: 0.077
-
2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2023 08 29; 148(9):e9-e119.
Score: 0.074
-
Demographic and Regional Trends of Cardiovascular Diseases and Diabetes Mellitus-Related Mortality in the United States From 1999 to 2019. Am J Med. 2023 07; 136(7):659-668.e7.
Score: 0.074
-
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2023 American College of Cardiology Conference. Curr Atheroscler Rep. 2023 06; 25(6):309-321.
Score: 0.073
-
The importance of low-density lipoprotein cholesterol measurement and control as performance measures: A joint Clinical Perspective from the National Lipid Association and the American Society for Preventive Cardiology. J Clin Lipidol. 2023 Mar-Apr; 17(2):208-218.
Score: 0.072
-
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2022 American Heart Association Scientific Sessions. Curr Atheroscler Rep. 2023 01; 25(1):31-41.
Score: 0.072
-
2022 ACC Expert Consensus Decision Pathway for Integrating Atherosclerotic Cardiovascular Disease and Multimorbidity Treatment: A Framework for Pragmatic, Patient-Centered Care: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2023 01 24; 81(3):292-317.
Score: 0.071
-
Demographic and Regional Trends of Hypertrophic Cardiomyopathy-Related Mortality in the United States, 1999 to 2019. Circ Heart Fail. 2022 09; 15(9):e009292.
Score: 0.070
-
Comparing eligibility for statin therapy for primary prevention under 2022 USPSTF recommendations and the 2018 AHA/ACC/ multi-society guideline recommendations: From National Health and Nutrition Examination Survey. Prog Cardiovasc Dis. 2022 Nov-Dec; 75:78-82.
Score: 0.070
-
Association Between Social Vulnerability Index and Cardiovascular Disease: A?Behavioral Risk Factor Surveillance System Study. J Am Heart Assoc. 2022 08 02; 11(15):e024414.
Score: 0.070
-
Persistent Racial/Ethnic Disparities in Cardiology Trainees in the United States. J Am Coll Cardiol. 2022 07 19; 80(3):276-279.
Score: 0.069
-
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2022 American College of Cardiology Scientific Sessions. Curr Atheroscler Rep. 2022 08; 24(8):671-680.
Score: 0.069
-
National trends and disparities in statin use for ischemic heart disease from 2006 to 2018: Insights from National Ambulatory Medical Care Survey. Am Heart J. 2022 10; 252:60-69.
Score: 0.069
-
Trends in Undiagnosed Diabetes Mellitus Among United States Adults: Cross-Sectional Analyses from NHANES 2011-2020. Am J Cardiol. 2022 07 15; 175:184-185.
Score: 0.069
-
State-Level Social Vulnerability Index and Healthcare Access: The Behavioral Risk Factor Surveillance System Survey. Am J Prev Med. 2022 09; 63(3):403-409.
Score: 0.068
-
Racial Disparities in Clinical Outcomes and Resource Utilization of Type 2 Myocardial Infarction in the United States: Insights From the National Inpatient Sample Database. Curr Probl Cardiol. 2023 Aug; 48(8):101202.
Score: 0.068
-
Association of premature atherosclerotic cardiovascular disease with higher risk of cancer: a behavioral risk factor surveillance system study. Eur J Prev Cardiol. 2022 Mar 25; 29(3):493-501.
Score: 0.068
-
Age-Related Disparity Trends in Stroke-Related Mortality in the United States, 1999 to 2019. Am J Cardiol. 2022 04 15; 169:162-163.
Score: 0.068
-
Prevalence and Predictors of Premature Coronary Heart Disease Among Asians in the United States: A National Health Interview Survey Study. Curr Probl Cardiol. 2023 Jul; 48(7):101152.
Score: 0.068
-
Potential Impact of the 2019 ACC/AHA Guidelines on the Primary Prevention of Cardiovascular Disease Recommendations on the Inappropriate Routine Use of Aspirin and Aspirin Use Without a Recommended Indication for Primary Prevention of Cardiovascular Disease in Cardiology Practices: Insights From the NCDR PINNACLE Registry. Circ Cardiovasc Qual Outcomes. 2022 03; 15(3):e007979.
Score: 0.067
-
Highlights of Cardiovascular Disease Studies Presented at the 2021 American Heart Association Scientific Sessions. Curr Atheroscler Rep. 2022 01; 24(1):61-72.
Score: 0.067
-
Determinants of Incident Atherosclerotic Cardiovascular Disease Events Among Those With Absent Coronary Artery Calcium: Multi-Ethnic Study of Atherosclerosis. Circulation. 2022 01 25; 145(4):259-267.
Score: 0.067
-
Trends in Patient-Recalled Targets for Cardiovascular Risk Factors in Ambulatory US Adults With Diabetes Mellitus (from National Health and Nutrition Examination Survey). Am J Cardiol. 2022 02 01; 164:143-145.
Score: 0.066
-
Association of patient, provider and facility related characteristics with statin associated side effects and statin use: Insight from the Veteran's Affairs healthcare system. J Clin Lipidol. 2021 Nov-Dec; 15(6):832-839.
Score: 0.066
-
Social vulnerability and COVID-19: An analysis of CDC data. Prog Cardiovasc Dis. 2022 Jul-Aug; 73:91-93.
Score: 0.066
-
A comparison of cardiovascular risk factors between Asian-Americans and non-Asian Americans: An analysis from the NHANES database. Prog Cardiovasc Dis. 2021 Sep-Oct; 68:94-96.
Score: 0.066
-
Gender disparities in difficulty accessing healthcare and cost-related medication non-adherence: The CDC behavioral risk factor surveillance system (BRFSS) survey. Prev Med. 2021 12; 153:106779.
Score: 0.065
-
Letter to the Editor: Temporal Changes in Cost-Related Medication Nonadherence by Race/Ethnicity and Medicaid Expansion: The Behavioral Risk Factor Surveillance System Survey. Popul Health Manag. 2022 02; 25(1):141-142.
Score: 0.065
-
Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) guidelines for management of dyslipidemia and cardiovascular disease risk reduction: Putting evidence in context. Prog Cardiovasc Dis. 2021 Sep-Oct; 68:2-6.
Score: 0.065
-
2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2021 08 31; 78(9):960-993.
Score: 0.065
-
Prevalence and predictors of cost-related medication nonadherence in individuals with cardiovascular disease: Results from the Behavioral Risk Factor Surveillance System (BRFSS) survey. Prev Med. 2021 12; 153:106715.
Score: 0.065
-
Sex-Related Disparities in Cardiovascular Health Care Among Patients With Premature Atherosclerotic Cardiovascular Disease. JAMA Cardiol. 2021 07 01; 6(7):782-790.
Score: 0.065
-
Disease-Specific Excess Mortality During the COVID-19 Pandemic: An Analysis of Weekly US Death Data for 2020. Am J Public Health. 2021 08; 111(8):1518-1522.
Score: 0.065
-
Substance Use and Premature Atherosclerotic Cardiovascular Disease (From the CDC Behavioral Risk Factor Surveillance System [BRFSS] Survey). Am J Cardiol. 2021 08 01; 152:177-178.
Score: 0.064
-
Health care costs associated with primary care physicians versus nurse practitioners and physician assistants. J Am Assoc Nurse Pract. 2021 05 31; 33(11):967-974.
Score: 0.064
-
Recreational substance use among patients with premature atherosclerotic cardiovascular disease. Heart. 2021 04; 107(8):650-656.
Score: 0.063
-
Clinical characteristics and mortality after acute myocardial infarction-related hospitalization among Asians from a national population-based cohort study. Prog Cardiovasc Dis. 2021 Jul-Aug; 67:108-110.
Score: 0.063
-
Facility-Level Variation in Reported Statin-Associated Side Effects Among Patients with Atherosclerotic Cardiovascular Disease-Perspective from the Veterans Affair Healthcare System. Cardiovasc Drugs Ther. 2022 04; 36(2):295-300.
Score: 0.063
-
Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association. Circulation. 2021 02 23; 143(8):e254-e743.
Score: 0.063
-
Racial disparities among Asian Americans with atrial fibrillation: An analysis from the NCDR? PINNACLE Registry. Int J Cardiol. 2021 04 15; 329:209-216.
Score: 0.062
-
Highlights from Studies Presented at the American Heart Association Scientific Session 2020: Navigating New Roads in Prevention. Curr Atheroscler Rep. 2021 01 03; 23(1):4.
Score: 0.062
-
State-Level Temporal Trends in Smokeless Tobacco and Cigarette Use Among U.S. Adults. Am J Cardiol. 2021 03 01; 142:145-147.
Score: 0.062
-
Temporal Trends in the Prevalence of Current E-Cigarette and Cigarette Use by Annual Household Income from 2016 to 2018 (from the Behavioral Risk Factor Surveillance System [BRFSS] Survey). Am J Cardiol. 2020 12 15; 137:139-140.
Score: 0.062
-
Letter to the Editor: Temporal Trends in E-Cigarette and Cigarette Use Among US Adults by US State: Behavioral Risk Factor Surveillance System, 2016 to 2018. Popul Health Manag. 2021 06; 24(3):414-415.
Score: 0.061
-
Eligibility for Low-Dose Rivaroxaban Based on the COMPASS Trial: Insights from the Veterans Affairs Healthcare System. Cardiovasc Drugs Ther. 2021 06; 35(3):533-538.
Score: 0.061
-
Statin Prescription Rates, Adherence, and Associated Clinical Outcomes Among Women with PAD and ICVD. Cardiovasc Drugs Ther. 2020 12; 34(6):745-754.
Score: 0.061
-
Association of Internet Use With the Use of Addictive Substances in the United States. Am J Cardiol. 2020 11 15; 135:182-183.
Score: 0.061
-
Racial and Geographic Disparities in Internet Use in the United States Among Patients with Atherosclerotic Cardiovascular Disease. Am J Cardiol. 2020 11 01; 134:146-147.
Score: 0.061
-
Premature Atherosclerotic Cardiovascular Disease: What Have We Learned Recently? Curr Atheroscler Rep. 2020 07 16; 22(9):44.
Score: 0.060
-
Association of Smokeless Tobacco Use With the Use of Other Illicit Drugs in the United States. Am J Med. 2021 01; 134(1):e15-e19.
Score: 0.060
-
Highlights of Studies in Cardiovascular Disease Prevention Presented at the 2020 American College of Cardiology Annual Scientific Session. Curr Atheroscler Rep. 2020 06 18; 22(8):32.
Score: 0.060
-
Secondary Prevention for Atherosclerotic Cardiovascular Disease: Comparing Recent US and European Guidelines on Dyslipidemia. Circulation. 2020 04 07; 141(14):1121-1123.
Score: 0.059
-
Temporal Trends in E-Cigarette Use Among U.S. Adults: Behavioral Risk Factor Surveillance System, 2016 to 2018. Am J Med. 2020 09; 133(9):e508-e511.
Score: 0.059
-
The Use of Sex-Specific Factors in the Assessment of Women's Cardiovascular Risk. Circulation. 2020 02 18; 141(7):592-599.
Score: 0.059
-
High-Sensitivity C-Reactive Protein Discordance With Atherogenic Lipid Measures and Incidence of Atherosclerotic Cardiovascular Disease in Primary Prevention: The ARIC Study. J Am Heart Assoc. 2020 02 04; 9(3):e013600.
Score: 0.059
-
Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association. Circulation. 2020 03 03; 141(9):e139-e596.
Score: 0.059
-
Cardiovascular Disease Prevention in Focus: Highlights from the 2019 American Heart Association Scientific Sessions. Curr Atheroscler Rep. 2020 01 11; 22(1):3.
Score: 0.058
-
Impact of Lipid Monitoring on Treatment Intensification of Cholesterol Lowering Therapies (from the Veterans Affairs Healthcare System). Am J Cardiol. 2020 03 15; 125(6):874-879.
Score: 0.058
-
Association between frequency of primary care provider visits and evidence-based statin prescribing and statin adherence: Findings from the Veterans Affairs system. Am Heart J. 2020 03; 221:9-18.
Score: 0.058
-
The use of structured data elements to identify ASCVD patients with statin-associated side effects: Insights from the Department of Veterans Affairs. J Clin Lipidol. 2019 Sep - Oct; 13(5):797-803.e1.
Score: 0.057
-
Very High-Risk ASCVD and Eligibility for Nonstatin Therapies Based on the 2018?AHA/ACC Cholesterol Guidelines. J Am Coll Cardiol. 2019 08 06; 74(5):712-714.
Score: 0.057
-
Relation Between Cardiology Follow-Up Visits, Evidence-Based Statin Prescribing, and Statin Adherence (from the Veterans Affairs Health Care System). Am J Cardiol. 2019 10 15; 124(8):1165-1170.
Score: 0.056
-
Provider-Level Variation in Smoking Cessation Assistance Provided in the Cardiology Clinics: Insights From the NCDR PINNACLE Registry. J Am Heart Assoc. 2019 07 02; 8(13):e011412.
Score: 0.056
-
Major Randomized Clinical Trials in Cardiovascular Disease Prevention Presented at the 2019 American College of Cardiology Annual Scientific Session. Curr Atheroscler Rep. 2019 05 24; 21(8):31.
Score: 0.056
-
Association Between Lipid Testing and Statin Adherence in the Veterans Affairs Health System. Am J Med. 2019 09; 132(9):e693-e700.
Score: 0.056
-
Facility-Level Variation in Stress Test Utilization in Veterans With Ischemic Heart Disease. JACC Cardiovasc Imaging. 2019 07; 12(7 Pt 1):1292-1293.
Score: 0.055
-
2018 Cholesterol Guidelines: Key Topics in Primary Prevention. Curr Atheroscler Rep. 2019 03 16; 21(5):17.
Score: 0.055
-
Eligibility and Cost for Icosapent Ethyl Based on the REDUCE-IT Trial. Circulation. 2019 03 05; 139(10):1341-1343.
Score: 0.055
-
Association of Body Mass Index With Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Cardiovascular Disease. Circ Cardiovasc Qual Outcomes. 2019 01; 12(1):e004817.
Score: 0.054
-
Facility-Level Variations in Kidney Disease Care among Veterans with Diabetes and CKD. Clin J Am Soc Nephrol. 2018 12 07; 13(12):1842-1850.
Score: 0.054
-
Lipid-Lowering Therapies: Risks in Women and Evidence-Based Options. Tex Heart Inst J. 2018 08; 45(4):238-239.
Score: 0.053
-
Variation in Lipid-Lowering Therapy Use in Patients With Low-Density Lipoprotein Cholesterol =190 mg/dL: Insights From the National Cardiovascular Data Registry-Practice Innovation and Clinical Excellence Registry. Circ Cardiovasc Qual Outcomes. 2018 05; 11(5):e004652.
Score: 0.052
-
Favorable Modifiable Cardiovascular Risk Profile Is Associated With Lower Healthcare Costs Among Cancer Patients: The 2012-2013 Medical Expenditure Panel Survey. J Am Heart Assoc. 2018 04 23; 7(9).
Score: 0.052
-
Statin prescription rates and their facility-level variation in patients with peripheral artery disease and ischemic cerebrovascular disease: Insights from the Department of Veterans Affairs. Vasc Med. 2018 06; 23(3):232-240.
Score: 0.052
-
Associations of Lipoprotein(a) Levels With Incident Atrial Fibrillation and Ischemic Stroke: The ARIC (Atherosclerosis Risk in Communities) Study. J Am Heart Assoc. 2017 Dec 15; 6(12).
Score: 0.051
-
Health Care Resource Utilization for Outpatient Cardiovascular Disease and Diabetes Care Delivery Among Advanced Practice Providers and Physician Providers in Primary Care. Popul Health Manag. 2018 06; 21(3):209-216.
Score: 0.050
-
Facility-level variation in diabetes and blood pressure control in patients with diabetes: Findings from the Veterans Affairs national database. Clin Cardiol. 2017 Nov; 40(11):1055-1060.
Score: 0.049
-
Association Between Modifiable Risk Factors and Pharmaceutical Expenditures Among Adults With Atherosclerotic Cardiovascular Disease in the United States: 2012-2013 Medical Expenditures Panel?Survey. J Am Heart Assoc. 2017 Jun 09; 6(6).
Score: 0.049
-
Estimation of Eligibility for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors and Associated Costs Based on the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk): Insights From the Department of Veterans Affairs. Circulation. 2017 06 20; 135(25):2572-2574.
Score: 0.048
-
Adoption of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline in Cardiology Practices Nationwide. JAMA Cardiol. 2017 04 01; 2(4):361-369.
Score: 0.048
-
Harder-to-Treat Patients: Recognizing Them and Adapting Treatment Strategies. Am J Cardiol. 2016 Sep 15; 118(6 Suppl):13A-8A.
Score: 0.046
-
Economic Impact of Moderate-Vigorous Physical Activity Among Those With and Without Established Cardiovascular Disease: 2012 Medical Expenditure Panel?Survey. J Am Heart Assoc. 2016 09 07; 5(9).
Score: 0.046
-
Comparative effectiveness of outpatient cardiovascular disease and diabetes care delivery between advanced practice providers and physician providers in primary care: Implications for care under the Affordable Care Act. Am Heart J. 2016 Nov; 181:74-82.
Score: 0.046
-
The 2013 ACC/AHA Cholesterol Management Guideline: Clearing the Confusion from Noncontroversial Components. Tex Heart Inst J. 2016 Aug; 43(4):313-4.
Score: 0.046
-
Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Peripheral Arterial and Ischemic Cerebrovascular Disease Compared to Veterans With Coronary Heart Disease. Am J Cardiol. 2016 Oct 15; 118(8):1144-1149.
Score: 0.046
-
Statin Use and Its Facility-Level Variation in Patients With Diabetes: Insight From the Veterans Affairs National Database. Clin Cardiol. 2016 Apr; 39(4):185-91.
Score: 0.045
-
Contemporary data on cardiovascular diseases in Indians: American College of Cardiology's PINNACLE India Quality Improvement Program. Indian Heart J. 2016 May-Jun; 68(3):434-5.
Score: 0.044
-
Case-based educational intervention to assess change in providers' knowledge and attitudes towards the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline. Atherosclerosis. 2016 Mar; 246:115-20.
Score: 0.044
-
Provider understanding of the 2013 ACC/AHA cholesterol guideline. J Clin Lipidol. 2016 May-Jun; 10(3):497-504.e4.
Score: 0.044
-
Implications for Ezetimibe Therapy Use Based on IMPROVE-IT Criteria. Am J Med. 2015 Nov; 128(11):1253-6.
Score: 0.042
-
Cardiovascular Disease Performance Measures in the Outpatient Setting in India: Insights From the American College of Cardiology's PINNACLE India Quality Improvement Program (PIQIP). J Am Heart Assoc. 2015 May 20; 4(5).
Score: 0.042
-
Coronary artery disease performance measures and statin use in patients with recent percutaneous coronary intervention or recent coronary artery bypass grafting (from the NCDR PINNACLE registry). Am J Cardiol. 2015 Apr 15; 115(8):1013-8.
Score: 0.041
-
Frequency and practice-level variation in inappropriate aspirin use for the primary prevention of cardiovascular disease: insights from the National Cardiovascular Disease Registry's Practice Innovation and Clinical Excellence registry. J Am Coll Cardiol. 2015 Jan 20; 65(2):111-21.
Score: 0.041
-
Is high-intensity statin therapy associated with lower statin adherence compared with low- to moderate-intensity statin therapy? Implications of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guidelines. Clin Cardiol. 2014 Nov; 37(11):653-9.
Score: 0.041
-
Relation between playing position and coronary artery calcium scores in retired National Football League players. Am J Cardiol. 2014 Dec 15; 114(12):1836-40.
Score: 0.040
-
Association between lipoprotein associated phospholipase A2 mass and subclinical coronary and carotid atherosclerosis in Retired National Football League players. Atherosclerosis. 2014 Oct; 236(2):251-6.
Score: 0.040
-
What is new in the 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic risk in adults? Tex Heart Inst J. 2014 Jun; 41(3):304-5.
Score: 0.040
-
Neck circumference is not associated with subclinical atherosclerosis in retired National Football League players. Clin Cardiol. 2014 Jul; 37(7):402-7.
Score: 0.039
-
Single nucleotide polymorphisms in cholesteryl ester transfer protein gene and recurrent coronary heart disease or mortality in patients with established atherosclerosis. Am J Cardiol. 2013 Nov 01; 112(9):1287-92.
Score: 0.037
-
Non-high-density lipoprotein cholesterol reporting and goal attainment in primary care. J Clin Lipidol. 2012 Nov-Dec; 6(6):545-52.
Score: 0.034
-
Association between traditional cholesterol parameters, lipoprotein particle concentration, novel biomarkers and carotid plaques in retired National Football League players. Atherosclerosis. 2012 Jun; 222(2):551-6.
Score: 0.034
-
Relation of cholesterol and lipoprotein parameters with carotid artery plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) carotid MRI study. Atherosclerosis. 2011 Dec; 219(2):596-602.
Score: 0.033
-
CDC WONDER: Trends in diabetes mellitus mortality in the United States from 1968 to 2021. Diabetes Res Clin Pract. 2025 Mar; 221:112012.
Score: 0.021
-
Trends in Cardiovascular Disease-Related Mortality in Texas. Tex Heart Inst J. 2024 Jul-Dec; 51(2):e248426.
Score: 0.021
-
Bayesian Model Projecting Cardiovascular Disease Related Mortality Trends in the United States. J Am Heart Assoc. 2024 Nov 05; 13(21):e035922.
Score: 0.020
-
A Case-Based Approach to the Management of Patients with Chronic Coronary Disease: Updates from the 2023 AHA/ACC Guidelines. Am J Med. 2025 Feb; 138(2):204-208.
Score: 0.020
-
Predictors of incident stroke among individuals without coronary artery calcification: A pooled cohort analysis from the Multi-Ethnic Study of Atherosclerosis, Jackson Heart Study, and Framingham Heart Study. Vasc Med. 2024 12; 29(6):632-639.
Score: 0.020
-
Comparing Cardiovascular Risk Classification of U.S. Adults According to Pooled Cohort Equations and PREVENT Equations: Cross-Sectional Analysis of the National Health and Nutrition Examination Survey. Ann Intern Med. 2024 Oct; 177(10):1444-1448.
Score: 0.020
-
Relationship between race, income-level, and Cardiovascular Disease. J Natl Med Assoc. 2024 Oct; 116(5):539-552.
Score: 0.020
-
Individual Variation in the Distribution of Apolipoprotein B Levels Across the Spectrum of LDL-C or Non-HDL-C Levels. JAMA Cardiol. 2024 Aug 01; 9(8):741-747.
Score: 0.020
-
Association between a diagnosis of diabetes mellitus and smoking abstinence: An analysis of the National Health Interview Survey (2006-2018). Prev Med. 2024 Oct; 187:108085.
Score: 0.020
-
Racial Differences in the Burden of Atherosclerotic Cardiovascular Disease Related to Elevated Lipoprotein(a) Levels: The ARIC Study. Circulation. 2024 Jul 16; 150(3):250-252.
Score: 0.020
-
What is the additive value of nutritional deficiency to VA-FI in the risk assessment for heart failure patients? J Nutr Health Aging. 2024 Jul; 28(7):100253.
Score: 0.020
-
Cardiovascular Health and Disease in the Pakistani American Population. Curr Atheroscler Rep. 2024 06; 26(6):205-215.
Score: 0.020
-
Trends of Cardiovascular Disease-Related Mortality in Breast Cancer in the United States From 1999 to 2019. Am J Cardiol. 2024 06 15; 221:110-112.
Score: 0.020
-
Prevalence of the Cardiovascular-Kidney-Metabolic Syndrome in the United States. J Am Coll Cardiol. 2024 May 07; 83(18):1824-1826.
Score: 0.020
-
Association of cardiovascular health with subclinical coronary atherosclerosis progression among five racial and ethnic groups: The MASALA and MESA studies. Atherosclerosis. 2024 05; 392:117522.
Score: 0.019
-
Trends in sleep apnea and heart failure related mortality in the United States from 1999 to 2019. Curr Probl Cardiol. 2024 Feb; 49(2):102342.
Score: 0.019
-
County-Level Cardiologist Density and Mortality in the United States. J Am Heart Assoc. 2023 12 05; 12(23):e031686.
Score: 0.019
-
Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific Statement From the American Heart Association. Circulation. 2023 12 12; 148(24):1982-2004.
Score: 0.019
-
Association between psychological distress and cardiovascular health amongst cancer survivors in the United States: findings from nationally representative data. Eur J Prev Cardiol. 2023 11 09; 30(16):e74-e77.
Score: 0.019
-
Clinicians' self-reported efficacy in cardiovascular prevention practice in the southeastern United States. Future Cardiol. 2023 09; 19(12):593-604.
Score: 0.019
-
Applying the ABCs of Cardiovascular Disease Prevention to the 2023 AHA/ACC Multisociety Chronic Coronary Disease Guidelines. Am J Med. 2024 02; 137(2):85-91.
Score: 0.019
-
A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association. Circulation. 2023 11 14; 148(20):1636-1664.
Score: 0.019
-
Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association. Circulation. 2023 11 14; 148(20):1606-1635.
Score: 0.019
-
Racial and Ethnic Disparities and Facility-Level Variation in GLP-1 RA Prescription among US Veterans with CKD. Clin J Am Soc Nephrol. 2023 11 01; 18(11):1479-1482.
Score: 0.019
-
2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic?Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2023 08 29; 82(9):833-955.
Score: 0.019
-
Low educational attainment is associated with higher all-cause and cardiovascular mortality in the United States adult population. BMC Public Health. 2023 05 16; 23(1):900.
Score: 0.018
-
Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association. Circulation. 2023 02 21; 147(8):e93-e621.
Score: 0.018
-
Characteristics and outcomes in acute myocardial infarction hospitalizations among the older population (age =80 years) in the United States, 2004-2018. Arch Gerontol Geriatr. 2023 08; 111:104930.
Score: 0.018
-
Family income and cardiovascular disease risk in American adults. Sci Rep. 2023 01 06; 13(1):279.
Score: 0.018
-
Lipid-Lowering Therapy Use and Intensification Among United States Veterans Following Myocardial Infarction or Coronary Revascularization Between 2015 and 2019. Circ Cardiovasc Qual Outcomes. 2022 12; 15(12):e008861.
Score: 0.018
-
The Impact of the Affordable Care Act on Disparities in Utilization of Cardiovascular Preventive Services by Socioeconomic Status. Popul Health Manag. 2022 10; 25(5):669-676.
Score: 0.018
-
Potential Impact of 2017 American College of Cardiology/American Heart Association Hypertension Guideline on Contemporary Practice: A Cross-Sectional Analysis From NCDR PINNACLE Registry. J Am Heart Assoc. 2022 06 07; 11(11):e024107.
Score: 0.017
-
Adherence to lipid monitoring and its impact on treat intensification of LDL-C lowering therapies at an urban academic medical center. J Clin Lipidol. 2022 Jul-Aug; 16(4):491-497.
Score: 0.017
-
Clinical and Economic Profile of Homeless Young Adults with Stroke in the United States, 2002-2017. Curr Probl Cardiol. 2023 Aug; 48(8):101190.
Score: 0.017
-
Reducing Cardiovascular Risk in the Medicare Million Hearts Risk Reduction Model: Insights From the National Cardiovascular Data Registry PINNACLE Registry. Circ Cardiovasc Qual Outcomes. 2022 04; 15(4):e007908.
Score: 0.017
-
Independent Association of Lipoprotein(a) and Coronary Artery Calcification With Atherosclerotic Cardiovascular Risk. J Am Coll Cardiol. 2022 03 01; 79(8):757-768.
Score: 0.017
-
Social determinants of health and obesity: Findings from a national study of US adults. Obesity (Silver Spring). 2022 02; 30(2):491-502.
Score: 0.017
-
Social Determinants of Health Among Non-Elderly Adults With Stroke in the United States. Mayo Clin Proc. 2022 02; 97(2):238-249.
Score: 0.017
-
Trends in Characteristics and Outcomes in Primary Heart Failure Hospitalizations Among Older Population in the United States, 2004 to 2018. Circ Heart Fail. 2022 05; 15(5):e008943.
Score: 0.017
-
Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association. Circulation. 2022 02 22; 145(8):e153-e639.
Score: 0.017
-
Trends in Premature Mortality From Acute Myocardial Infarction in the United States, 1999 to 2019. J Am Heart Assoc. 2022 01 04; 11(1):e021682.
Score: 0.017
-
Clinical and Economic Burden of Percutaneous Coronary Intervention in Hospitalized Young Adults in the United States, 2004-2018. Curr Probl Cardiol. 2022 Nov; 47(11):101070.
Score: 0.017
-
Effects of the 2021 CKD-EPI Creatinine eGFR Equation among a National US Veteran Cohort. Clin J Am Soc Nephrol. 2022 02; 17(2):283-285.
Score: 0.017
-
Cardiovascular Disease Risk-Based Statin Utilization and Associated Outcomes in a Primary Prevention Cohort: Insights From a Large Health Care Network. Circ Cardiovasc Qual Outcomes. 2021 09; 14(9):e007485.
Score: 0.016
-
Trends in Characteristics and Outcomes of Hospitalized Young Patients Undergoing Coronary Artery Bypass Grafting in the United States, 2004 to 2018. J Am Heart Assoc. 2021 09 07; 10(17):e021361.
Score: 0.016
-
Scope and Social Determinants of Food Insecurity Among Adults With Atherosclerotic Cardiovascular Disease in the United States. J Am Heart Assoc. 2021 08 17; 10(16):e020028.
Score: 0.016
-
Comparative Outcomes of Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction Among Medicare Beneficiaries With Multivessel Coronary Artery Disease: An National Cardiovascular Data Registry Research to Practice Project. Circ Cardiovasc Interv. 2021 08; 14(8):e010323.
Score: 0.016
-
Social Determinants of Health and Cardiovascular Disease: Current State and Future Directions Towards Healthcare Equity. Curr Atheroscler Rep. 2021 07 26; 23(9):55.
Score: 0.016
-
Lipid Monitoring After Initiation of Lipid-Lowering Therapies: Return of Performance Measures? Curr Cardiol Rep. 2021 07 16; 23(9):116.
Score: 0.016
-
Stroke-Related Mortality in the United States-Mexico Border Area of the United States, 1999 to 2018. J Am Heart Assoc. 2021 07 06; 10(13):e019993.
Score: 0.016
-
Temporal Changes and Institutional Variation in Use of Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction With Multivessel Coronary Artery Disease in the United States: An NCDR Research to Practice Project. JAMA Cardiol. 2021 05 01; 6(5):574-580.
Score: 0.016
-
Transatlantic guidelines on dyslipidemia and cardiovascular risk: key differences across the pond. Curr Opin Endocrinol Diabetes Obes. 2021 04 01; 28(2):114-121.
Score: 0.016
-
Association of NT-ProBNP, Blood Pressure, and Cardiovascular Events: The ARIC Study. J Am Coll Cardiol. 2021 02 09; 77(5):559-571.
Score: 0.016
-
Trends in pneumococcal vaccination in patients presenting with acute coronary syndrome in the United States. Prog Cardiovasc Dis. 2021 Jul-Aug; 67:111-113.
Score: 0.016
-
Sociodemographic Disparities in Influenza Vaccination Among Adults With Atherosclerotic Cardiovascular Disease in the United States. JAMA Cardiol. 2021 01 01; 6(1):87-91.
Score: 0.016
-
Trends and Predictors of Transcatheter Aortic Valve Implantation Related In-Hospital Mortality (From the National Inpatient Sample Database). Am J Cardiol. 2021 03 15; 143:97-103.
Score: 0.016
-
Sex Differences in the Age of Diagnosis for Cardiovascular Disease and Its Risk Factors Among US Adults: Trends From 2008 to 2017, the Medical Expenditure Panel Survey. J Am Heart Assoc. 2020 12 15; 9(24):e018764.
Score: 0.015
-
Association Between Sociodemographic Determinants and Disparities in Stroke Symptom Awareness Among US Young Adults. Stroke. 2020 12; 51(12):3552-3561.
Score: 0.015
-
Revascularization Practices and Outcomes in Patients With Multivessel Coronary Artery Disease Who Presented With Acute Myocardial Infarction and Cardiogenic Shock in the US, 2009-2018. JAMA Intern Med. 2020 10 01; 180(10):1317-1327.
Score: 0.015
-
Nondietary Cardiovascular Health Metrics With Patient Experience and Loss of Productivity Among US Adults Without Cardiovascular Disease: The Medical Expenditure Panel Survey 2006 to 2015. J Am Heart Assoc. 2020 10 20; 9(19):e016744.
Score: 0.015
-
Lipoprotein(a) and Family History Predict Cardiovascular Disease Risk. J Am Coll Cardiol. 2020 08 18; 76(7):781-793.
Score: 0.015
-
Meditation and Cardiovascular Health in the US. Am J Cardiol. 2020 09 15; 131:23-26.
Score: 0.015
-
Treatment of AF in American Indians and Alaska Natives: Insights From the NCDR PINNACLE-AF Registry. J Am Coll Cardiol. 2020 06 02; 75(21):2749-2750.
Score: 0.015
-
Obesity and the paradox of mortality and heart failure hospitalization in heart failure with preserved ejection fraction. Int J Obes (Lond). 2020 07; 44(7):1561-1567.
Score: 0.015
-
Age-Stratified Sex Disparities in Care and Outcomes in Patients With ST-Elevation Myocardial Infarction. Am J Med. 2020 11; 133(11):1293-1301.e1.
Score: 0.015
-
Cumulative Burden of Financial Hardship From Medical Bills Across the Spectrum of Diabetes Mellitus and Atherosclerotic Cardiovascular Disease Among Non-Elderly Adults in the United States. J Am Heart Assoc. 2020 05 18; 9(10):e015523.
Score: 0.015
-
Beliefs, risk perceptions, and lipid management among patients with and without diabetes: Results from the PALM registry. Am Heart J. 2020 07; 225:88-96.
Score: 0.015
-
Pet Ownership and Cardiovascular Health in the US General Population. Am J Cardiol. 2020 04 15; 125(8):1158-1161.
Score: 0.015
-
Burden and Consequences of Financial Hardship From Medical Bills Among Nonelderly Adults With Diabetes Mellitus in the United States. Circ Cardiovasc Qual Outcomes. 2020 02; 13(2):e006139.
Score: 0.015
-
Association between intensity of statin therapy and mortality in persons with chronic kidney disease. Nephrol Dial Transplant. 2020 02 01; 35(2):312-319.
Score: 0.015
-
Trends in U.S. Ambulatory Cardiovascular Care 2013 to 2017: JACC Review Topic of the Week. J Am Coll Cardiol. 2020 01 07; 75(1):93-112.
Score: 0.015
-
Association Between Poverty and Appropriate Statin Prescription for the Treatment of Hyperlipidemia in the United States: An Analysis From the ACC NCDR PINNACLE Registry. Cardiovasc Revasc Med. 2020 08; 21(8):1016-1021.
Score: 0.015
-
Variation and Disparities in Awareness of Myocardial Infarction Symptoms Among Adults in the United States. JAMA Netw Open. 2019 12 02; 2(12):e1917885.
Score: 0.014
-
Cost-Related Medication Nonadherence in Adults With Atherosclerotic Cardiovascular Disease in the United States, 2013 to 2017. Circulation. 2019 12 17; 140(25):2067-2075.
Score: 0.014
-
Medical Therapy Utilization and Long-Term Outcomes Following Percutaneous Coronary Intervention: Five-Year Results From the Veterans Affairs Clinical Assessment, Reporting, and Tracking System Program. Circ Cardiovasc Qual Outcomes. 2019 11; 12(11):e005455.
Score: 0.014
-
Intensity of Lipid Lowering With Statin Therapy in Patients With Cerebrovascular Disease Versus Coronary Artery Disease: Insights from the PALM Registry. J Am Heart Assoc. 2019 10; 8(19):e013229.
Score: 0.014
-
Prescription Patterns of Clopidogrel, Prasugrel, and Ticagrelor After Percutaneous Coronary Intervention With Stent Implantation (from the NCDR PINNACLE Registry). Am J Cardiol. 2019 12 15; 124(12):1807-1812.
Score: 0.014
-
Gaps in provider lifestyle counseling and its adherence among obese adults with prediabetes and diabetes in the United States. Prev Med. 2019 12; 129:105815.
Score: 0.014
-
Sex Differences in the Use of Statins in Community Practice. Circ Cardiovasc Qual Outcomes. 2019 08; 12(8):e005562.
Score: 0.014
-
High-Sensitive Troponin T, Natriuretic Peptide, and Cognitive Change. J Am Geriatr Soc. 2019 11; 67(11):2353-2361.
Score: 0.014
-
Total cholesterol/HDL-cholesterol ratio discordance with LDL-cholesterol and non-HDL-cholesterol and incidence of atherosclerotic cardiovascular disease in primary prevention: The ARIC study. Eur J Prev Cardiol. 2020 10; 27(15):1597-1605.
Score: 0.014
-
The Interplay of the Global Atherosclerotic Cardiovascular Disease Risk Scoring and Cardiorespiratory Fitness for the Prediction of All-Cause Mortality and Myocardial Infarction: The Henry Ford ExercIse Testing Project (The FIT Project). Am J Cardiol. 2019 08 15; 124(4):511-517.
Score: 0.014
-
Practice-level variation in statin use and low-density lipoprotein cholesterol control in the United States: Results from the Patient and Provider Assessment of Lipid Management (PALM) registry. Am Heart J. 2019 08; 214:113-124.
Score: 0.014
-
Four Cases of Cholesterol Management Informed by the 2018 American Heart Association/American College of Cardiology Multisociety Guideline on the Management of Blood Cholesterol. JAMA Cardiol. 2019 05 01; 4(5):473-477.
Score: 0.014
-
Patient-Reported Reasons for Declining or Discontinuing Statin Therapy: Insights From the PALM Registry. J Am Heart Assoc. 2019 04 02; 8(7):e011765.
Score: 0.014
-
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 09 10; 140(11):e563-e595.
Score: 0.014
-
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 09 10; 140(11):e596-e646.
Score: 0.014
-
Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation. 2019 03 05; 139(10):e56-e528.
Score: 0.014
-
Financial Hardship From Medical Bills Among Nonelderly U.S. Adults With Atherosclerotic Cardiovascular Disease. J Am Coll Cardiol. 2019 02 19; 73(6):727-732.
Score: 0.014
-
Association of Clinician Knowledge and Statin Beliefs With Statin Therapy Use and Lipid Levels (A Survey of US Practice in the PALM Registry). Am J Cardiol. 2019 04 01; 123(7):1011-1018.
Score: 0.014
-
Influence of Cardiovascular Risk Communication Tools and Presentation Formats on Patient Perceptions and Preferences. JAMA Cardiol. 2018 12 01; 3(12):1192-1199.
Score: 0.014
-
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task?Force?on?Clinical Practice Guidelines. J Am Coll Cardiol. 2019 06 25; 73(24):3168-3209.
Score: 0.013
-
Use of Risk Assessment Tools to?Guide?Decision-Making in the?Primary?Prevention of Atherosclerotic?Cardiovascular Disease: A Special Report From the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2019 06 25; 73(24):3153-3167.
Score: 0.013
-
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task?Force?on?Clinical Practice Guidelines. J Am Coll Cardiol. 2019 06 25; 73(24):e285-e350.
Score: 0.013
-
Variation in the Use of Warfarin and Direct Oral Anticoagulants in Atrial Fibrillation and Associated Cost Implications. Am J Med. 2019 01; 132(1):61-70.e1.
Score: 0.013
-
Measurement of Low-Density Lipoprotein Cholesterol Levels in Primary and Secondary Prevention Patients: Insights From the PALM Registry. J Am Heart Assoc. 2018 09 18; 7(18):e009251.
Score: 0.013
-
Association of Patient Perceptions of Cardiovascular Risk and Beliefs on Statin Drugs With Racial Differences in Statin Use: Insights From the Patient and Provider Assessment of Lipid Management Registry. JAMA Cardiol. 2018 08 01; 3(8):739-748.
Score: 0.013
-
Statin Eligibility, Coronary Artery Calcium, and Subsequent Cardiovascular Events According to the 2016 United States Preventive Services Task Force (USPSTF) Statin Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Heart Assoc. 2018 06 13; 7(12).
Score: 0.013
-
Ticagrelor Use in Acute Myocardial Infarction: Insights From the National Cardiovascular Data Registry. J Am Heart Assoc. 2018 06 09; 7(12).
Score: 0.013
-
Frequency of Statin Use in Patients With Low-Density Lipoprotein Cholesterol =190 mg/dl from the Veterans Affairs Health System. Am J Cardiol. 2018 09 01; 122(5):756-761.
Score: 0.013
-
Life's Simple 7 and the risk of atrial fibrillation: The Multi-Ethnic Study of Atherosclerosis. Atherosclerosis. 2018 08; 275:174-181.
Score: 0.013
-
Cardiovascular Disease Prevention: Training Opportunities, the Challenges, and Future Directions. Curr Atheroscler Rep. 2018 05 21; 20(7):35.
Score: 0.013
-
Statin Use and Adverse Effects Among Adults >75?Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry. J Am Heart Assoc. 2018 05 08; 7(10).
Score: 0.013
-
Impact of Patient-Centered Medical Home Implementation on Diabetes Control in the Veterans Health Administration. J Gen Intern Med. 2018 08; 33(8):1276-1282.
Score: 0.013
-
Prevalence and Management of Symptoms Associated With Statin Therapy in Community Practice: Insights From the PALM (Patient and Provider Assessment of Lipid Management) Registry. Circ Cardiovasc Qual Outcomes. 2018 03; 11(3):e004249.
Score: 0.013
-
Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association. Circulation. 2018 03 20; 137(12):e67-e492.
Score: 0.013
-
National Trends in Nonstatin Use and Expenditures Among the US Adult Population From 2002 to 2013: Insights From Medical Expenditure Panel?Survey. J Am Heart Assoc. 2018 01 22; 7(2).
Score: 0.013
-
Persistent socioeconomic disparities in cardiovascular risk factors and health in the United States: Medical Expenditure Panel Survey 2002-2013. Atherosclerosis. 2018 02; 269:301-305.
Score: 0.013
-
Clinical pharmacist understanding of the 2013 American College of Cardiology/American Heart Association cholesterol guideline. J Clin Lipidol. 2018 Mar - Apr; 12(2):367-374.e3.
Score: 0.013
-
Updated Cost-effectiveness Assessments of PCSK9 Inhibitors From the Perspectives of the Health System and Private Payers: Insights Derived From the FOURIER Trial. JAMA Cardiol. 2017 12 01; 2(12):1369-1374.
Score: 0.013
-
Burden of Catastrophic Health Expenditures for Acute Myocardial Infarction and Stroke Among Uninsured in the United States. Circulation. 2018 01 23; 137(4):408-410.
Score: 0.013
-
Implications of the FDA approval of PCSK9 inhibitors and FOURIER results for contemporary cardiovascular practice: An NCDR Research to Practice (R2P) project. Am Heart J. 2018 01; 195:151-152.
Score: 0.012
-
Life's Simple 7 and Incident Heart Failure: The Multi-Ethnic Study of Atherosclerosis. J Am Heart Assoc. 2017 Jun 27; 6(6).
Score: 0.012
-
The association of lipoprotein(a) with incident heart failure hospitalization: Atherosclerosis Risk in Communities study. Atherosclerosis. 2017 07; 262:131-137.
Score: 0.012
-
Patient-Provider Communication and Health Outcomes Among Individuals With Atherosclerotic Cardiovascular Disease in the United States: Medical Expenditure Panel Survey 2010 to 2013. Circ Cardiovasc Qual Outcomes. 2017 04; 10(4).
Score: 0.012
-
Favorable cardiovascular risk factor profile is associated with lower healthcare expenditure and resource utilization among adults with diabetes mellitus free of established cardiovascular disease: 2012 Medical Expenditure Panel Survey (MEPS). Atherosclerosis. 2017 03; 258:79-83.
Score: 0.012
-
BNP and obesity in acute decompensated heart failure with preserved vs. reduced ejection fraction: The Atherosclerosis Risk in Communities Surveillance Study. Int J Cardiol. 2017 Apr 15; 233:61-66.
Score: 0.012
-
Association Between Intensity of Statin Therapy and Mortality in Patients With Atherosclerotic Cardiovascular Disease. JAMA Cardiol. 2017 01 01; 2(1):47-54.
Score: 0.012
-
Association between high-sensitivity troponin T and cardiovascular risk in individuals with and without metabolic syndrome: The ARIC study. Eur J Prev Cardiol. 2017 04; 24(6):628-638.
Score: 0.012
-
Implications of the LEGACY trial on US Atrial Fibrillation Patients: An NCDR Research to Practice (R2P) Project. Am J Cardiol. 2017 02 15; 119(4):579-584.
Score: 0.012
-
Antihypertensive adherence and outcomes among community-dwelling Medicare beneficiaries: the Atherosclerosis Risk in Communities Study. J Eval Clin Pract. 2018 02; 24(1):48-55.
Score: 0.012
-
Use of high-intensity statins for patients with atherosclerotic cardiovascular disease in the Veterans Affairs Health System: Practice impact of the new cholesterol guidelines. Am Heart J. 2016 Dec; 182:97-102.
Score: 0.012
-
American College of Cardiology (ACC)'s PINNACLE India Quality Improvement Program (PIQIP)-Inception, progress and future direction: A report from the PIQIP Investigators. Indian Heart J. 2016 Dec; 68 Suppl 3:S1-S4.
Score: 0.012
-
Biomarkers and degree of atherosclerosis are independently associated with incident atherosclerotic cardiovascular disease in a primary prevention cohort: The ARIC study. Atherosclerosis. 2016 10; 253:156-163.
Score: 0.012
-
Antiplatelet Management for Coronary Heart Disease: Advances and Challenges. Curr Atheroscler Rep. 2016 Jun; 18(6):35.
Score: 0.011
-
Lipid Management Guidelines from the Departments of Veteran Affairs and Defense: A?Critique. Am J Med. 2016 09; 129(9):906-12.
Score: 0.011
-
A Systematic Review of the Prevalence and Outcomes of Ideal Cardiovascular Health in US?and Non-US Populations. Mayo Clin Proc. 2016 05; 91(5):649-70.
Score: 0.011
-
Favorable Cardiovascular Risk Profile Is Associated With Lower Healthcare Costs and Resource Utilization: The 2012 Medical Expenditure Panel Survey. Circ Cardiovasc Qual Outcomes. 2016 Mar; 9(2):143-53.
Score: 0.011
-
The impact of multiple single day blood pressure readings on cardiovascular risk estimation: The Atherosclerosis Risk in Communities study. Eur J Prev Cardiol. 2016 09; 23(14):1529-36.
Score: 0.011
-
Executive Summary: Heart Disease and Stroke Statistics--2016 Update: A Report From the American Heart Association. Circulation. 2016 Jan 26; 133(4):447-54.
Score: 0.011
-
Effect of Long-Term Periodontal Care on Hemoglobin A1c in Type 2 Diabetes. J Dent Res. 2016 Apr; 95(4):408-15.
Score: 0.011
-
Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation. 2016 Jan 26; 133(4):e38-360.
Score: 0.011
-
Design and rationale for the Patient and Provider Assessment of Lipid Management (PALM) registry. Am Heart J. 2015 Nov; 170(5):865-71.
Score: 0.011
-
Relationship of the triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio to the remainder of the lipid profile: The Very Large Database of Lipids-4 (VLDL-4) study. Atherosclerosis. 2015 Sep; 242(1):243-50.
Score: 0.011
-
Frequency of Attainment of Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol Goals in Cardiovascular Clinical Practice (from the National Cardiovascular Data Registry PINNACLE Registry). Am J Cardiol. 2015 Aug 15; 116(4):547-53.
Score: 0.011
-
Eligibility for statin therapy according to new cholesterol guidelines and prevalent use of medication to lower lipid levels in an older US Cohort: the Atherosclerosis Risk in Communities Study Cohort. JAMA Intern Med. 2015 Jan; 175(1):138-40.
Score: 0.010
-
Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation. 2015 Jan 27; 131(4):e29-322.
Score: 0.010
-
Implications of the 2013 ACC/AHA cholesterol guidelines for adults in contemporary cardiovascular practice: insights from the NCDR PINNACLE registry. J Am Coll Cardiol. 2014 Dec 02; 64(21):2183-92.
Score: 0.010
-
High-sensitivity troponin T and cardiovascular events in systolic blood pressure categories: atherosclerosis risk in communities study. Hypertension. 2015 Jan; 65(1):78-84.
Score: 0.010
-
Perioperative beta blockade in noncardiac surgery: a systematic review for the 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014 Dec 09; 130(24):2246-64.
Score: 0.010
-
Perioperative beta blockade in noncardiac surgery: a systematic review for the 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2014 Dec 09; 64(22):2406-25.
Score: 0.010
-
Prognostic significance of hyponatremia among ambulatory patients with heart failure and preserved and reduced ejection fractions. Am J Cardiol. 2014 Jun 01; 113(11):1834-8.
Score: 0.010
-
Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study. Arterioscler Thromb Vasc Biol. 2014 May; 34(5):1069-77.
Score: 0.010
-
Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation. 2014 Jan 21; 129(3):399-410.
Score: 0.010
-
Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation. 2014 Jan 21; 129(3):e28-e292.
Score: 0.010
-
Ceruloplasmin and heart failure in the Atherosclerosis Risk in Communities study. Circ Heart Fail. 2013 Sep 01; 6(5):936-43.
Score: 0.009
-
Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation. 2013 Jan 01; 127(1):143-52.
Score: 0.009
-
Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation. 2013 Jan 01; 127(1):e6-e245.
Score: 0.009
-
Impact of clinical complexity on the quality of diabetes care. Am J Manag Care. 2012 09; 18(9):508-14.
Score: 0.009
-
A genetic risk score based on direct associations with coronary heart disease improves coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC), but not in the Rotterdam and Framingham Offspring, Studies. Atherosclerosis. 2012 Aug; 223(2):421-6.
Score: 0.009
-
Medicare eligibility and physician utilization among adults with coronary heart disease and stroke. Med Care. 2012 Jun; 50(6):547-53.
Score: 0.009
-
ST elevation: telling pathology from the benign patterns. Glob J Health Sci. 2012 Apr 28; 4(3):51-63.
Score: 0.009
-
Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation. 2012 Jan 03; 125(1):188-97.
Score: 0.008
-
Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation. 2012 Jan 03; 125(1):e2-e220.
Score: 0.008
-
Clinical implications of JUPITER (Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) in a U.S. population insights from the ARIC (Atherosclerosis Risk in Communities) study. J Am Coll Cardiol. 2009 Dec 15; 54(25):2388-95.
Score: 0.007